CULLEN COLLEGE OF ENGINEERING

University of Houston Cullen College of Engineering

News

Engineering Research Shows Potential for Helping Lupus Patients

Printer-friendly versionSend by emailPDF version

By: 

Elena Watts
Tianfu Wu

Lupus is a chronic autoimmune disease without a cure and without a highly effective treatment option. Many scientists believe that genetics and environmental factors interact to cause immune cells in the human body to overreact and attack healthy cells and organs in the estimated 1.5 million Americans affected by the disease.

“Over time, 50 to 60 percent of lupus patients end up with renal failure caused by kidney disease, and they also have higher incidents of cardiovascular disease and other health issues,” said Tianfu Wu, assistant professor of biomedical engineering at the UH Cullen College of Engineering. “So it’s a dangerous disease, and we want to find a cure or at least more potent treatments than exist now.”

Wu earned a $300,000 grant from the Lupus Research Institute, LRI, to continue his pursuit of promising preliminary lupus research. He systematically scanned entire proteins inside cells and determined that one molecule called polo-like kinase 1, or PLK1, might contribute to the onset of the disease.

Wu identified three goals for his LRI grant. First, he intends to uncover a molecular basis for the immune cells that express PLK1 as well as signature pathways used by PLK1 to regulate upstream and downstream molecules. Next, he aims to determine whether or not PLK1 is an effective therapeutic target for treatment of lupus in animal models. Lastly, Wu plans to collaborate with the UT Health Science Center in the Texas Medical Center to translate results found in animal models to human patients.

During the last 50 years, the FDA has approved only one drug, Benlysta, for the specific treatment of lupus. However, in randomized, double-blind, placebo-controlled clinical trials, the patients who received this drug showed only slightly better results than the patients who received the placebo. Other lupus treatments, such as steroids and antimalarial drugs, were not originally designed to treat the disease, but suppress immune responses and inflammation. Unfortunately, they can also cause a host of problematic side effects with prolonged use.

“Hopefully this LRI-funded research will advance our understanding of the pathogenesis of lupus,” Wu said. “And the blockade of PLK1 could become a novel and effective strategy in conquering this devastating disease.”

Faculty: 

Department: 

Tag: 

Related News Stories

UH Alumnus Appointed Chair of Engineering Department of Turkish University

Hasan Onur Keles, a UH BME alumnus, appointed chair of the electrical and electronic engineering department at Istinye University in Istanbul.

An engineering connection spanning continents and countries

 

Cullen College of Engineering alumnus Hasan Onur Keles (BME 2015) was recently appointed chair of the electrical and electronic engineering department at Istinye University in Istanbul. He also serves as an assistant professor in the department.

UH Student’s Poster Places at Neuromodulation Symposium

Musa Ozturk, a UH graduate student, stands in front of the award-winning poster with Jianping Wu, senior principal scientist at Medtronic and co-author of the study.

Research proposes computer-based assessment of Parkinson’s patients more reliable

 

Musa Ozturk, a Ph.D. student in biomedical engineering at the UH Cullen College of Engineering, presented a poster at the Neuromodulation Symposium at the University of Minnesota and won second place out of 120 presentations.

Mission: Possible — Mapping Dangerous Terrain

UH researchers are testing prototypes for the project in Brays Bayou.

UH Engineers Focus on Degradable Reconnaissance Vehicles and Evasive Drone Maneuvers

 

Ensuring military forces have up-to-date information about a potentially hostile region offers obvious advantages, but current methods for doing that – especially along shorelines, where underwater mines and other hazards can pose serious risks – all have drawbacks. It is especially difficult if keeping the technology out of enemy hands is a priority.

Upcoming Events / Seminars